Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
Completed
Conditions studied: Hemophilia A
In brief
To correlate the Human Leukocyte Antigen type and genetic defect with hemophilia A.
Key facts
- Study ID
- NCT00178607
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 99
- Starts
- 2002-08-01
- Expected to finish
- 2015-10-01
- Last updated by the study team
- 2016-05-12
Who can join
Age: 0 and older, up to 99. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Severe Hemophilia A with an inhibitor level of 0.6 B.U. or higher
You may not qualify if…
- Severe Hemophilia A with a negative inhibitor
Where it is running
- The Univeristy of Texas Health Science Center at Houston — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.